Categories Earnings, Technology

Twitter (TWTR) Q4 earnings preview: Product issues to hurt results

Twitter Inc. (NYSE: TWTR) is slated to report its fourth-quarter 2019 earnings results on Thursday before the market opens. The bottom line will be hurt by higher costs and expenses related to revenue product issues and seasonality while the strength in US advertising continues to drive the top-line growth.

The top-line growth rate is likely to be lesser than previous quarters due to the negative impact of its mobile application promotion advertisements and the issues in personalization and data settings. The ad engagements are likely to increase year-over-year as audience and clickthrough rates across most ad formats could drive ad impressions for the quarter.

Read: Facebook Q4 earnings review

Most of the advertising revenue is generated by selling its promoted products. This consists of promoted tweets, which appear within a timeframe, search results or profile pages just like an ordinary tweet regardless of device, promoted accounts, and promoted trends.

The company is expected to continue investing in revenue products as it works to improve ads platform and ad formats to deliver increased value to advertisers around the world. Advertising revenue continued to be driven by sales momentum with advertisers, built around differentiated ad formats, better relevance, and improved return on investment.

Analysts expect the company’s earnings to decline by 6.50% to $0.29 per share while revenue will jump by 9.70% to $996.73 million for the fourth quarter. The company has surprised investors by beating analysts’ expectations thrice in the past four quarters. The majority of the analysts recommended a “hold” rating with an average price target of $34.08.

Read: Twitter stock in recovery mode on growth prospects

For the third quarter, Twitter posted a 95% dip in earnings due to an increase in costs and expenses. Revenue grew by 9% on strength in US advertising while revenue product issues and greater-than-expected seasonality reduced the top-line growth rate. The double-digit increases in both domestic and international ad revenue drove advertising revenue higher by 8%.

For the fourth quarter, the company expects total revenue in the range of $0.94-1.01 billion and operating income in the range of $130-170 million. For the full year 2019, capital expenditures are anticipated to be at or near the low end of the prior forecast range of $550-600 million. The stock-based compensation expense is now projected to be at or near the midpoint of its previous outlook of $350-400 million.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Comments

  1. Pingback: Arie Baisch
  2. Pingback: Chirurgie Tunisie
  3. Pingback: Higher education
  4. Pingback: Marketing program
  5. Pingback: Bachelor's Degree
  6. Pingback: Computer Science
  7. Pingback: Admission Process
  8. Pingback: fue
  9. Pingback: Medication safety
  10. Pingback: Clinical dentistry
  11. Pingback: FCIT Programs
  12. Pingback: pannello led
  13. Pingback: torso rotary
  14. Pingback: Fiverr Earn
  15. Pingback: Fiverr Earn
  16. Pingback: endopump
  17. Pingback: livpure mediprime
  18. Pingback: fiverrearn.com
  19. Pingback: fiverrearn.com
  20. Pingback: french bulldog
  21. Pingback: chiweenie lifespan
  22. Pingback: bernedoodles
  23. Pingback: blockchain
  24. Pingback: vietravel tour
  25. Pingback: zodiac jewelry
  26. Pingback: Pure copper ring
  27. Pingback: future university
  28. Pingback: future university
  29. Pingback: future university
  30. Pingback: future university
  31. Pingback: multisbo rtp
  32. Pingback: bulldogs puppy
  33. Pingback: Fiverr
  34. Pingback: future university
  35. Pingback: Piano maintenance
  36. Pingback: Piano tuning
  37. Pingback: FUE
  38. Pingback: Classic Books 500
  39. Pingback: FiverrEarn
  40. Pingback: Fiverr.Com
  41. Pingback: FiverrEarn
  42. Pingback: Aussie Porn Stars
  43. Pingback: pupuk organik
  44. Pingback: partners
  45. Pingback: tonic greens
  46. Pingback: Econometrics
  47. Pingback: endopeak
  48. Pingback: Betting tips
  49. Pingback: live sex cams
  50. Pingback: FiverrEarn
  51. Pingback: FiverrEarn
  52. Pingback: FiverrEarn
  53. Pingback: FiverrEarn
  54. Pingback: FiverrEarn
  55. Pingback: FiverrEarn
  56. Pingback: FiverrEarn
  57. Pingback: FiverrEarn
  58. Pingback: FiverrEarn
  59. Pingback: FiverrEarn
  60. Pingback: FiverrEarn
  61. Pingback: FiverrEarn
  62. Pingback: FiverrEarn
  63. Pingback: technology
  64. Pingback: web design
  65. Pingback: Slot Thailand
  66. Pingback: cheap sex cams
  67. Pingback: live sex cams
  68. Pingback: frt trigger
  69. Pingback: 늑대닷컴
  70. Pingback: slot online gacor
  71. Pingback: nangs sydney
  72. Pingback: allgame
  73. Pingback: 918kiss
  74. Pingback: หวย24
  75. Pingback: pg slot
  76. Pingback: AI Attorney
  77. Pingback: cybersécurité
  78. Pingback: judi online
  79. Pingback: resort lake placid
  80. Pingback: 6.5 grendel ammo
  81. Pingback: SaaS Attorney
  82. Pingback: ItMe.Xyz
  83. Pingback: ItMe.Xyz
  84. Pingback: masumintl.com
  85. Pingback: masumintl

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top